← Browse by Condition
Medical Condition
cachexia
Total Trials
7
Recruiting Now
7
Trial Phases
Phase 3
ClinicalMetric tracks all active clinical trials for cachexia sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — cachexia Clinical Trials
How many clinical trials are currently recruiting for cachexia?
ClinicalMetric currently tracks 7 actively recruiting clinical trials for cachexia, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 7. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for cachexia?
cachexia research spans Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a cachexia clinical trial?
Eligibility criteria for cachexia trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT04627376
Recruiting
Multimodal Program for Cancer Related Cachexia Prevention
Enrollment
60 pts
Location
Cyprus
Sponsor
Cyprus University of Technolog...
NCT05723718
Recruiting
MalnutritiOn Assessment With biOelectrical impedaNce Analysis in gastRic Cancer patIentS Undergoing Multimodal trEatment
Enrollment
125 pts
Location
Poland
Sponsor
Medical University of Lublin
NCT07083557
Recruiting
Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
Enrollment
100 pts
Location
United States
Sponsor
Bettina Mittendorfer
NCT05899205
Recruiting
Patient Recorded Indexing Measurements
Enrollment
300 pts
Location
Netherlands
Sponsor
Academisch Ziekenhuis Maastric...
NCT06517199 Phase 3
Recruiting
Olanzapine for Cancer Related Anorexia-cachexia Syndrome
Enrollment
138 pts
Location
Thailand
Sponsor
Mahidol University
NCT05642819
Recruiting
REVOLUTION Surgery (REVOLUTION Surgery)
Enrollment
200 pts
Location
United Kingdom
Sponsor
University of Edinburgh
NCT06986265
Recruiting
CKD Cachexia and Gut Microbiome
Enrollment
157 pts
Location
Belgium
Sponsor
Université Catholique de Louva...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology